Nucleus RadioPharma

Nucleus RadioPharma

Private
Davidson, North CarolinaHealthcare & Life Scienceshttps://www.nucleusrad.com

Last Round

Series A

Extension

Jun 5, 2024

Total Funding Raised

$62M

Momentum Score

25 /100

Company Overview

Nucleus RadioPharma is a biopharmaceutical company focused on developing innovative treatments and technologies for cancer research and therapeutic radiopharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Clinical Trials, Smart Manufacturing, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radiopharmaceutical manufacturingCDMOtargeted radiotherapyradiopharmaceuticalscontract development and manufacturingradiopharmaceutical supply chainradioligand therapyjust-in-time manufacturingtheranosticsradioisotopespharma logisticsclinical trial supplynuclear medicineprecision medicineregulatory support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nucleus RadioPharma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nucleus RadioPharma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 5, 2024
Series AOct 17, 2023
SeedOct 18, 2022

Key People

Founding team and executive leadership

Steve Hahn

Chief Executive Officer

Executive Team

Joe Warchol

Chief Financial Officer

Executive Team

Nucleus RadioPharma Investors

Notable investors and investment history

InvestorRounds
Granger ManagementSeries A
University of MissouriSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 86% MoM, reaching 3.4K.

  • Apr 14, 2026

    Planned manufacturing facility in Spring House, Pennsylvania.

Nucleus RadioPharma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nucleus RadioPharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nucleus RadioPharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersDavidson, North Carolina
Employee Range57
Year Founded2022
Last FundingJun 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.